Growth Metrics

Bio-Techne (TECH) Current Deferred Revenue (2016 - 2025)

Bio-Techne (TECH) has 12 years of Current Deferred Revenue data on record, last reported at $31.0 million in Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 2.07% year-over-year to $31.0 million; the TTM value through Dec 2025 reached $31.0 million, up 2.07%, while the annual FY2025 figure was $32.6 million, 7.85% up from the prior year.
  • Current Deferred Revenue reached $31.0 million in Q4 2025 per TECH's latest filing, down from $32.7 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $35.6 million in Q1 2025 and bottomed at $19.1 million in Q4 2021.
  • Average Current Deferred Revenue over 5 years is $26.4 million, with a median of $26.2 million recorded in 2023.
  • Peak YoY movement for Current Deferred Revenue: skyrocketed 53.27% in 2021, then decreased 1.44% in 2023.
  • A 5-year view of Current Deferred Revenue shows it stood at $19.1 million in 2021, then rose by 23.16% to $23.5 million in 2022, then increased by 28.09% to $30.1 million in 2023, then increased by 1.0% to $30.4 million in 2024, then increased by 2.07% to $31.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $31.0 million in Q4 2025, $32.7 million in Q3 2025, and $32.6 million in Q2 2025.